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Introduction
Studies have shown an association between anti-retro 
viral therapies (ART) and different degrees of sexual 
dysfunction in men.[1-3] The highest rates of dysfunction are 
associated with Indinavir and the lowest with Nevirapine.[2] 
Among people living with HIV/AIDS (PLWHA) on ART, 
sexual dysfunctions have been reported in form of erectile 
dysfunction (ED) (9–74%), ejaculatory disturbances 
(36–42%), and low sexual desire (24–73%).[3] Ejaculatory 
dysfunction has been shown to be associated with the use of 
didanosine, as well as other protease inhibitors.[3,4]
These sexual dysfunctions could be of psychogenic or organic 
etiology.
There is also a subdivision into mental, hormonal, 
pharmacological, and other morbid conditions. Hypogonadism 
was one of the most frequent causes of sexual dysfunction before 
the advent of highly active anti-retroviral therapy (HAART), 
and it still remains the most common endocrine disorder of 
HIV-infected men.[5] After receiving the diagnosis of HIV 
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Background: Erectile dysfunctions (EDs) are common presentations among men on 
anti‑retroviral therapy, many of who had a course to discontinue anti‑retroviral drugs or search 
for alternative treatments. Aim: This study assessed the prevalence and predictors of ED among 
men on anti‑retro viral therapies (ART) in a Nigerian population. Subjects and Methods: It was 
a descriptive cross‑sectional survey among 234 HIV‑positive men on anti‑retroviral therapy 
selected using stratified sampling method after excluding for co‑morbidities. Research 
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analyzed using the SPSS software version 17.0 (Chicago IL, USA), while binary logistic 
regression and Chi‑square test were used to demonstrate association between selected 
categorical variable. Results: Mean age of respondents was 37.1 (1.6) years, 85.6% have not 
missed their medications, self‑reported adherence was reported as good among 213 [(90.8 %) 
213/234], though calculated adherence was 90% among as many as 201 [(85.6%) 201/234]. 
Pattern of EDs revealed weak erection among 42 [(37.8%) 42/111], 15 [(13.5%) 15/111] 
said they could no longer achieve erection, 33 [(29.7%) 33/111] said they could not maintain 
erections, while 27 [(24.3%) 27/111] presented with loss of libido. Delayed and premature 
ejaculations were reported among 24 [(21.6%) 24/111] and 8 [(7.2%) 8/111] respectively. 
About 14% (33/234) of respondents said that anti‑retroviral drugs could have caused their ED 
while 78% (183/234) said it should not. A statistically significant association exists between 
having weak erections and age above 65 years and calculated the adherence <95%, while none 
exists between having weak erections and missing pills. Conclusion: Anti‑retroviral drugs are 
common causes of EDs. Concerns of clients should always be addressed most especially issues 
that may compromise adherence.
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infection, it is common for people to experience negative 
moods, show less interest in sex and decrease the frequency 
of sexual activity. Depression is one of the important mental 
factors associated with sexual dysfunctions.[1,6]
In addition, HIV-infected individuals use many other 
medications that could also be associated with decreased sexual 
responses. Medications such as ketoconazole, fluconazole, 
ganciclovir, megestrol, methadone, and antipsychotics 
including antidepressants may decrease testosterone levels 
and cause sexual dysfunctions.[7] Sexual dysfunction has an 
impact on the quality of life and very often leads to negative 
attitudes on the part of the individual, including poor adherence 
to antiretroviral (ARV) regimens and to safer sex strategies.[8-10]
Huge data gap exists on pattern of ED in Nigeria most 
especially among PLWHA. Even among few studies done 
outside Nigeria, most emphasis were laid on 2nd line ART 
and clients on salvage therapy, with little or no emphasis 
on clients on first line ART which constitutes majority of 
HIV-positive Nigerians on ART addressed by this study. 
Despite few prevalence figures reported, the pathophysiology 
of sexual dysfunction in the HAART era is still not completely 
understood. We investigated the prevalence of ED in a cohort 
of HIV-infected people on ART, to identify risk factors 
for developing ED among HIV-infected men especially in 
developing countries where many socio-economic factors 
influence clients’ management and outcomes.
Subjects and Methods
Study design
The study was a descriptive cross-sectional survey carried out 
in Osogbo, Osun State.
Study area
Osogbo is the capital of Osun State in South-western Nigeria. 
HIV treatment, care and support in the capital city, takes 
place in the secondary (State Government Hospital) and 
tertiary (State Government University Teaching Hospital) 
health care levels. Primary health care centers were mainly for 
HIV counseling and testing services, and were excluded from 
this study. HIV prevalence in the city was 2.5%, a bit lower 
than the national average put at 4.1%.
Study population
Target population constitutes HIV positive men accessing 
treatment in some selected health facilities. Eligible men 
would have been on ART for at least 1-year. In addition, 
men on medications that could influence erectile functions 
(such as ketoconazole, fluconazole, ganciclovir, megestrol, 
methadone, and antipsychotics including antidepressants) 
were totally excluded from this study. Co-morbidities such as 
hypertension and diabetes that could also serve as confounders 
were also excluded among study participants through past 
medical history. Using Leslie Fischer’s formula for calculation 
of sample size for the population <10,000, a sample size of 
221 was estimated, and this was increased to 240 to account 
for non-response. A total of 250 questionnaires were taken to 
the field.
There were two eligible facilities in Osogbo, Asubiaro General 
Hospital, which is secondary, and LAUTECH Teaching 
Hospital which is tertiary in nature, and both have about 2000 
registered clients on ART. Questionnaires were equally shared 
among the 2 facilities. On a bi-weekly clinic day per facility, a 
list or sampling frame of all eligible men was obtained from the 
triage nurse. A systematic sampling of one in three eligible men 
on the list was done, and this continued until the questionnaires 
allocated for that day got exhausted. Apart from pre-testing 
and training of data collectors, data validity were further 
ensured by translating and back-translating the questionnaire 
between English and the native Yoruba languages-to assist 
further understanding among the illiterate and semi-literate 
respondents. Study period was from January 2013 to June 2013.
Data were collected by trained research assistants using 
pre-tested interviewer administered semi-structured 
questionnaires. Interviews were conducted under strict 
confidentiality and privacy in the post‑test counseling rooms 
of the clinics. Details of the study and its objectives were 
explained to all respondents and participation voluntary, 
informed consent was obtained from each participant. 
Ethical clearance was obtained from Osun State University, 
Osogbo ethical review committee. Permission was also 
obtained from the Project Coordinators of the respective 
HIV/ART program as well as the Medical Director of the 
health facilities used.
Questionnaires were manually sorted out and data obtained 
were entered into the computer. Statistical Package for social 
Sciences (SPSS) version 17 (Chicago IL, USA) was used 
to analyze the double-entered data that were also checked 
for outlier values to ensure its validity. Frequency tables 
were generated, and relevant summary measures calculated. 
The Chi-square test was used to demonstrate an association 
between categorical variables while level of significance for 
the statistical tests was considered at P < 0.05.
Results
Mean age of respondents was 37.1 (1.6) years, 88.2% (207/234) 
were married, and 74.8% (175/234) had up to secondary 
school level education as seen in Table 1. Table 2 showed that 
about 85.6% (201/234) have not missed their medications, 
self-reported adherence was reported as good among 
90.8% (213/234), though calculated adherence was 90% 
among as many as 85.6% (201/234).
Pattern of EDs as shown in Table 3 revealed weak erection 
among 37.8% (42/111), 13.5% (15/111) said they could no 
Adebimpe et al.: Erectile dysfunctions among men on anti‑retroviral therapy
Annals of Medical and Health Sciences Research | Jul-Aug 2015 | Vol 5 | Issue 4 | 281
Table 1: Sociodemographic characteristics of respondents



























Table 2: Pattern of adherence to ART
Variable Frequency (n=234) Percentage
Missed medications
In the last 6 months 15 6.6
In the last 1‑month 9 3.9












1‑5 years 194 82.9
>5 years 40 17.1
ART regimen
1st line 234 100.0









Figure 1: Respondents’ perception about anti‑retroviral therapy being 
the cause of their sexual dysfunction
longer achieve erection, 29.7% (33/111) said they could not 
maintain erections, while 24.3% (27/111) presented with loss 
of libido.
Delayed and premature ejaculations were reported among 
21.6% (24/111) and 7.2% (8/111), respectively. Figure 1 
showed that about 14% (33/234) of respondents said that 
ARVs could have caused their ED while 78% (183/234) 
said it should not. Table 4 showed statistically significant 
association (P < 0.01) between having weak erections and 
age above 65 years, and calculated adherence <95%, while 
none exists between having weak erections and missing 
pills (P = 0.17).
Respondents with age >40 years are two and a half times 
more likely to develop ED compared to respondents with 
age <40 years (P = 0.35; odds ratio [OR] =2.5; 95% confidence 
interval [CI] =0.56–2.35). There is no observed difference 
between the different education levels of respondents 
coming-up with weak erections (P = 0.08; OR = 1.1; 95% 
CI = 0.66–1.94). Respondents who have also missed their 
pills were about four and a half times more likely to have 
weak erections compared to those who have not missed 
their medication in the last 6 months (P = 0.01; OR = 44.7; 
95% CI = 1.14–19.39). However, respondents with longer 
duration of being on ART (>5 years) are three times more 
likely to develop EDs compared to those who had been on 
ART for < 5 years (P < 0.01; OR = 0.3; 95% CI = 0.01–0.11). 
Respondents with calculated adherence level above 90% 
were five times more likely to have developed weak erections 
compared to those with poor adherence (<90%), in which 
case (P < 0.01; OR = 5.1; 95% CI = 2.01–13.09). Thus, poor 
adherence to ART, longer duration of being on ART, missing 
of ART medications and older age are predictors of having 
EDs or weak erection on binary logistic regression analysis.
Discussion
Mean age of respondents was 37.1 (1.6) years, 207 (88.2%) 
were married, 175 (74.8%) had up to secondary school level 
education, About 80% of respondents never missed their 
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anti-retroviral drug between the last 1-week up to 6 months 
preceding the study, but only 3 (1.3%) of all the respondents 
had optimal calculated adherence (>95%), 80% of them had 
their calculated adherence in the range of 90–95%. Being 
male has been shown to be significantly associated with 
non-adherence to ART.[11]
Almost half of the respondents reported having (or experiencing) 
various symptoms suggestive of ED. This is in congruence 
with previous studies.[1,12-18] A study carried out in Spain 
demonstrated a high prevalence of ED in HIV-infected men 
and also highlighted the self-perception of respondents about 
their body changes and mental health with all sexual function 
domains.[13] This study also showed that almost a quarter of 
the respondents that reported sexual dysfunction said they had 
totally lost sexual libido.
The causes of sexual dysfunction vary from endocrinological, 
psychogenic, neurogenic, arteriogenic or iatrogenic.[18] 
Numerous medications are also known to cause sexual 
dysfunction and studies have suggested that a decrease in 
sexual interest and ED were found in individuals who are on 
HAART,[1,3,18] especially if their regimens contain Protease 
Inhibitors.[3,18] This study also showed that respondents who are 
on ART could have weak erection in spite of their adherence. 
Almost 20% of respondents >65 years of age were found to 
significantly have weak erection. Older age is one of the risk 
factors for ED.[1,19]
This study has demonstrated sexual dysfunctions among 
PLWHA. Further research may be needed to improve the 
description of the development of sexual dysfunctions in such 
individuals so as to identify pathophysiological mechanisms 
and to study the management/treatment of this disorder. 
The recovery of the sexual function, associated with a good 
adherence to safe sex practices, will improve the quality of 
life of the PLWHAs.
Findings from binary logistic regression in this study proved 
wrong the notion that there is no age difference among those 
HIV positive clients having ED and those not having it. Atrophy 
of old age could also explain this phenomenon. Similarly, 
statistical difference exists to prove any alternative hypothesis 
supporting that there is a difference between adherence pattern 
and duration of taking ART among those who developed ED 
compared to those not having ED. Thus, clinicians working in 
ART clinics should be wary of all possible implications of weak 
erections among clients on ART most especially those in the 
middle age or older age groups. It is important that clinicians 
take priority in ensuring that medications of those who had 
been on ART for long are reviewed from time to time to prevent 
this menace of ED among HIV-positive men.
Though this study evidently excluded drugs that may serve as 
cofounders, and employed oral (and some common laboratory 
tests) methods to exclude possible common organic causes 
of ED as stated, a need for further sophisticated methods of 
excluding remote causes may be necessary in future studies.
Conclusion
Antiretroviral are common causes of EDs among HIV-positive 
men on ART. Many of such men may have contemplated 
missing their ARV drugs or seek alternative care elsewhere 
when these menstrual abnormalities are getting unbearable. 
Stakeholders in Art care should always strive to address 
concerns of clients, most especially issues that may 
compromise ARV adherence.
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